Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
107,809,066
-
Total 13F shares
-
286,675
-
Share change
-
+13,093
-
Total reported value
-
$8,769,009
-
Price per share
-
$30.49
-
Number of holders
-
5
-
Value change
-
+$383,052
-
Number of buys
-
2
-
Number of sells
-
2
Institutional Holders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) as of Q4 2023
As of 31 Dec 2023,
Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
286,675 shares.
The largest 10 holders included
ARK Investment Management LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., MORGAN STANLEY, WELLINGTON MANAGEMENT GROUP LLP, Deep Track Capital, LP, and FEDERATED HERMES, INC..
This page lists
289
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.